The Dexcom G6 Continuous CGM system has been added to the devices available through the Australian Government’s CGM Subsidy Initiative.
A research breakthrough, funded by JDRF, has shown a promising future for the prevention of type 1 diabetes. Findings from a study by TrialNet show that the immunotherapy drug teplizumab can delay type 1 diabetes diagnosis a median of 2 years in children and adults at high risk. The study showed that teplizumab interferes with […]
Right now, we’re in our houses more than ever before. We work, learn, sleep and socialise in our house. That’s a lot of time inside! You’ve probably found as social distancing restrictions are easing that you’ve developed some habits which make managing type 1 diabetes trickier because you’ve been cooped up indoors. Stuff like staying up late and sleeping in, trouble […]
This content was co-written by Simone Collins, Diabetes Social Worker at Canberra Health Services and Melanie Cullen, Paediatric Psychologist and Insulin Pump Program Coordinator at JDRF Australia for families of children newly diagnosed with T1D. The outbreak of COVID-19 has impacted people in all walks of life on an international scale. Our lives have been […]
If you have been following JDRF across our social channels, or have been speaking to any of our diligent advocates, you may have heard of Kids in the House. Curious as to what it is? And how you can support? Then read on! What is Kids in the House? Kids in the House is the […]
The JDRF-led Type 1 Diabetes Clinical Research Network is currently recruiting for a study which could help reduce eye complications for people with type 1 diabetes. See full study details here, or email the FAME-1 study team at fame1eye@ctc.usyd.edu.au.
